November 16, 2026
Transcript
Nick Lanyi
Welcome to CAP News. I'm Nick Lanyi with the College of American Pathologists. It's Monday, November 16th. It was a promise that sounded almost too good to be true. Hundreds of medical tests from just a single drop of blood. It turned Elizabeth Holmes into a billionaire, and then it all came crashing down. Now the box office smash documentary, You Can See Everything, follows the disgraced Theranos founder in the weeks before she begins a prison sentence for defrauding investors. Holmes had claimed the company's Edison device could revolutionize laboratory testing. It never worked. The Theranos story has become a cautionary tale about what can happen when bold claims about laboratory medicine get ahead of the science. What the movie doesn't mention is that one group was always skeptical about Theranos' technology. Pathologists. Dr. Olga Pozdnyakova, a pathologist from the University of Pennsylvania, says the promise of running hundreds of tests from a tiny blood sample simply didn't square with the science.
Dr. Olga Pozdnyakova
So from my perspective and from perspective of laboratorians and pathologists, I think almost everyone understood that it's not scientifically possible to do that.
Nick Lanyi
She wasn't alone. Pathologists like Dr. Brian Jackson from the University of Maryland Medical School say the problems with Theranos' claims were apparent from the start.
Dr. Brian Jackson
Everyone I spoke with in the pathology and laboratory communities knew from day one that this was impossible. I didn't talk, I I cannot remember speaking with a single person within our world who thought that this was remotely, you know, in the in the the the realm of possibility.
Nick Lanyi
So why couldn't the Edison device work? One reason is that different tests require different specimens.
Dr. Olga Pozdnyakova
For example, some tests require just plain blood, the one that it's it hasn't been um uh changed or anything, just straight from from the tube. Some tests require heparinized blood, so this is when we add some thinners to the blood tube so the blood doesn't clot. Some tests require not the entire blood, but only blood components. For example, it could be performed on plasma, so this is something that's completely devoid, or serum completely devoid of the cells, or it could be performed just on the cells. What we want to avoid is basically ticking off all the boxes of all the possible types of lab tests that could present in a patient with slightly abnormal bleeding factors and or a suspected bleeding history. So just the idea that you can run this various tests uh that require a very different specimen type is by itself, um I don't think it's scientifically possible.
Nick Lanyi
Different tests also mean a wide range of reagents, substances that are added to the blood to create a reaction.
Dr. Brian Jackson
To people outside of the pathology laboratory world, um they think that when they think tests, they think, you know, Star Trek, tricorder kind of a thing, that they're not thinking about the the enormous variety of methods that we use in the laboratory.
Dr. Olga Pozdnyakova
The idea that you take all of the reagents for 200 and 40, 50, 300 tests, and you all mix them together and you tell uh the system to somehow parse it out and perform all these different tests with a mixture of these reagents. So that's another claim which I think is uh more on the fantasy level than actually reality.
Nick Lanyi
Yet another problem was the amount of blood from a finger prick, only a few microliters.
Dr. Brian Jackson
It violated the basic laws of physics. So from I mean, from a chemistry and physics standpoint, um you need a a certain quality, certain quantity of sample to be able to, you know, run a particular type of reaction.
Dr. Olga Pozdnyakova
I give you an example, something that I'm very familiar with is when we do complete blood cell count, we require at least one milliliter of blood, right? So we're not dealing with microliters, we're we're dealing with one milliliter of blood. For some uh chemical tests, immunoassays, you may require much more because you actually separate cells from plasma and and you do this testing. So it may be three to five milliliters of blood.
Nick Lanyi
Theranos came crashing down after the Wall Street Journal published an expose of the company and its fraudulent claims, an "I told you so" moment for pathologists.
Dr. Olga Pozdnyakova
We felt validated that uh uh we do lab medicine uh for a reason, and lab medicine requires a lot of regulations, and those regulations are there for a reason. You cannot just uh, I don't know, open the shop in someone's garage and say, okay, from now on I'll be providing medical services and measuring your, I don't know, prostate-specific antigen levels.
Dr. Brian Jackson
Yeah, this this is an old story. You know, con men and women have been around for a very long time. So this isn't, in a sense, it's nothing new. It just was putting a sort of a Silicon Valley flavored uh slash medical technology flavored, you know, veneer on top of a very old kind of a of a tactic.
Nick Lanyi
Dr. Jackson says medicine needs to adhere to scientific standards like transparency, peer review, and reproducibility of results. That didn't happen.
Dr. Brian Jackson
So we have this whole system of science that's really indispensable. And uh Theranos violated all of that. Theranos followed the Silicon Valley set of ethics, which is um exaggerate everything, um, that hype is okay because it's how you raise money, um, and you keep everything close to the vest.
Nick Lanyi
And that may be the larger lesson as artificial intelligence moves deeper into medicine. The technology will change, but the need for scientific scrutiny, transparency, and accountability won't. The question is whether those guardrails can keep pace with what comes next. That does it for this episode of CAP News. Share this newscast with your social media network. If you're watching this video on YouTube, hit the like button and leave a comment. And if you've got a story we should be covering, write to us at stories at CAP.org. We'll be back tomorrow at 5 AM Eastern for another episode of our newscast. I'm Nick Lanyi. Have a wonderful day.